Back to search
FDAFDA · Food and drugs·Recall number D-0684-2017

Triamcinolone Diacetate 40 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1021, barcode 3 70285 10211 0.

Published May 3, 2017 · Recall initiated: April 6, 2017

Summary

FDA records drug Class II recall D-0684-2017, published May 3, 2017 and initiated April 6, 2017. Recalling firm: Isomeric Pharmacy Solution, LLC; Status: Terminated; Reported quantity: 1,951 vials; Lot: Lot #s: 10013, Exp 05/10/17; 10020, Exp 05/20/17; 10029, Exp 05/27/17; 11002, Exp 05/30/17; 11013, Exp 06/04/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Isomeric Pharmacy Solution, LLC
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot #s: 10013, Exp 05/10/17; 10020, Exp 05/20/17; 10029, Exp 05/27/17; 11002, Exp 05/30/17; 11013, Exp 06/04/17.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Triamcinolone Diacetate 40 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1021, barcode 3 70285 10211 0. recalled?

Yes. FDA published recall D-0684-2017 on May 3, 2017. Reported hazard: Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit